Atopic Dermatitis Clinical Trials
Atopic Dermatitis clinical trials study new biologics, small-molecule drugs, and treatment approaches for atopic Dermatitis and related immune or inflammatory conditions. Corterve gathers actively recruiting Atopic Dermatitis studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Atopic Dermatitis studies
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaNCT07783425PHASE3PfizerAtopic DermatitisPhoenix, Arizona
- First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic DermatitisNCT07527923PHASE1Regeneron PharmaceuticalsHealthy VolunteerBirmingham, Alabama
- Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic DermatitisNCT07262983PHASE1National Institute of Allergy and Infectious Diseases (NIAID)Hyper IgE Syndrome From STAT3 MutationBethesda, Maryland
- A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisNCT07223697PHASE2Hoffmann-La RocheAtopic DermatitisLos Angeles, California
- Studies of Skin Microbes in Healthy People and in People With Skin ConditionsNCT00605878National Human Genome Research Institute (NHGRI)EczemaBethesda, Maryland
- Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234NCT07453602PHASE1Arcutis Biotherapeutics, Inc.Atopic Dermatitis (AD)Miami, Florida
- Natural History and Genetics of Food Allergy and Related ConditionsNCT02504853National Institute of Allergy and Infectious Diseases (NIAID)Food AllergyBethesda, Maryland
- A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)NCT06808477PHASE1Bambusa TherapeuticsAtopic DermatitisIrvine, California
- This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic TreatmentNCT07290803SanofiAtopic DermatitisBirmingham, Alabama
- Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic DermatitisNCT06947993PHASE2Novartis PharmaceuticalsAtopic DermatitisBirmingham, Alabama
- A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe EczemaNCT06807281PHASE3PfizerAtopic DermatitisBirmingham, Alabama
- Study of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisNCT07298395PHASE2Enveda TherapeuticsAtopic Dermatitis (AD)Birmingham, Alabama
Atopic Dermatitis trials by state
Atopic Dermatitis trials by metro
Frequently asked questions
- How do I find recruiting Atopic Dermatitis clinical trials?
- Browse the actively recruiting Atopic Dermatitis studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Atopic Dermatitis clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Atopic Dermatitis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.